Furthermore, mice lacking TLR4 or RAGE are intrinsically less susceptible to seizures and less prone to developing epilepsy (5, 15), suggesting that HMGB1 is implicated in epileptogenesis and that therefore, its targeting may have therapeutic utility. Here, TLR4 is linked to epilepsy.